Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Pharmaceutical Composition Containing pGLU-GLU-PRO-NH2 and Method for Treating Diseases and Injuries to the Brain, Spinal Cord and Retina Using Same

Riepilogo

In accordance with 37 CFR 404.6, announcement is made of the availability for licensing of U.S. Patent Application No. 09/692,938 entitled "Pharmaceutical Composition Containing pGLU-GLU-PRO-NH2 and Method for Treating Diseases and Injuries to the Brain, Spinal Cord and Retina Using Same" and filed October 20, 2000. Foreign rights are also available (PCT/US00/29278). The United States Government, as represented by the Secretary of the Army, has rights in this invention.